Shields et al., 1994 - Google Patents
Noncontact transscleral Nd: YAG cyclophotocoagulation: a long-term follow-up of 500 patients.Shields et al., 1994
View PDF- Document ID
- 11823333634746367664
- Author
- Shields M
- Shields S
- Publication year
- Publication venue
- Transactions of the American Ophthalmological Society
External Links
Snippet
Long-term experience with transscleral cyclophotocoagulation in 500 patients suggests that this operation is the cyclodestructive procedure of choice. It offers a reasonable surgical option in the high-risk glaucoma population, which includes patients with neovascular …
- 238000000034 method 0 abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00872—Cornea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shields et al. | Noncontact transscleral Nd: YAG cyclophotocoagulation: a long-term follow-up of 500 patients. | |
Plager et al. | Intermediate-term results of endoscopic diode laser cyclophotocoagulation for pediatric glaucoma | |
Robin et al. | A comparison of neodymium: YAG end argon laser iridotomies | |
Sun et al. | Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term | |
Chen et al. | Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas | |
Wagle et al. | Long-term outcome of cyclocryotherapy for refractory pediatric glaucoma | |
Hennis et al. | Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma | |
Neely et al. | Endocyclophotocoagulation for management of difficult pediatric glaucomas | |
Landers et al. | Treatment of retinopathy of prematurity with argon laser photocoagulation | |
Kramp et al. | Transscleral diode laser contact cyclophotocoagulation in the treatment of different glaucomas, also as primary surgery | |
Lam et al. | Efficacy and safety of immediate anterior chamber paracentesis in the treatment of acute primary angle-closure glaucoma: a pilot study | |
Shingleton et al. | Surgical goniosynechialysis for angle-closure glaucoma | |
Patel et al. | Endolaser treatment of the ciliary body for uncontrolled glaucoma | |
Munden et al. | Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C | |
Rebolleda et al. | Audible pops during cyclodiode procedures | |
Tan et al. | Endoscopic cyclophotocoagulation and pars plana ablation (ECP-plus) to treat refractory glaucoma | |
Brancato et al. | Diode laser compared with argon laser for trabeculoplasty | |
Del Priore et al. | Neodymium: YAG and argon laser iridotomy: long-term follow-up in a prospective, randomized clinical trial | |
Geyer | Management of large, leaking, and inadvertent filtering blebs with the neodymium: YAG laser | |
Pathak-Ray et al. | Phaco-endocycloplasty versus phacotrabeculectomy in primary angle-closure glaucoma: a prospective randomized study | |
Badeeb et al. | Short-term effects of neodymium-YAG transscleral cyclocoagulation in patients with uncontrolled glaucoma. | |
Rodriguez et al. | Intravitreal triamcinolone acetonide injection in blind painful eyes: intraocular steroids as a treatment for blind painful red eyes | |
Slagle et al. | Nonpenetrating deep sclerectomy for progressive glaucoma: long-term (5-year) follow-up of intraocular pressure control and visual field survival | |
RU2575966C2 (en) | Method of treating neovascular glaucoma | |
Quiroz-Mercado et al. | Vitreous management in massive suprachoroidal hemorrhage |